Advertisement

Botulinum Neurotoxin Treatment of Palmar and Plantar Hyperhidrosis

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Dermatologic Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Strutton D.R.
        • Kowalski J.W.
        • Glaser D.A.
        • et al.
        US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.
        J Am Acad Dermatol. 2004; 51: 241-248
        • Lin T.S.
        • Fang H.Y.
        Transthoracic endoscopic sympathectomy in the treatment of palmar hyperhidrosis—with emphasis on perioperative management (1360 case analyses).
        Surg Neurol. 1999; 52: 453-457
        • Lakraj A.A.
        • Moghimi N.
        • Jabari B.
        Hyperhidrosis: anatomy, pathophysiology and treatment with emphasis on the role of botulinum toxins.
        Toxins (Basel). 2013; 5: 821-840
        • Hornberger J.
        • Grimes K.
        • Naumann M.
        Recognition, diagnosis, and treatment of primary focal hyperhidrosis.
        J Am Acad Dermatol. 2004; 51: 274-278
        • Naumann M.K.
        • Hamm J.
        • Lowe N.J.
        Effect of botulinum toxin type A on quality of life measures in patients with excessive maxillary sweating: a randomized controlled trial.
        Br J Dermatol. 2002; 147: 1218-1226
        • Sato K.
        The physiology, pharmacology and biochemistry of the eccrine sweat gland.
        Rev Physiol Biochem Pharmacol. 1997; 79: 51-131
        • Lear W.
        • Kessler E.
        • Solish N.
        An epidemiological study of hyperhidrosis.
        Dermatol Surg. 2007; 33: S69-S75
        • Manca D.
        • Valls-Sole J.
        • Callejas M.A.
        Excitability recovery curve of the sympathetic skin response in healthy volunteers and patients with palmar hyperhidrosis.
        Clin Neurophysiol. 2000; 111: 1767-1770
        • Glaser D.A.
        • Herbert A.A.
        • Pariser D.M.
        • et al.
        Palmar and plantar hyperhidrosis: best practice recommendations and special considerations.
        Cutis. 2007; 79: 18-28
        • Wooley-Loyd H.
        • Valins W.
        Aluminum chloride hexahydrate in a salicylic acid gel base: a case series of combination therapy with botulinum toxin type A for moderate to severe hyperhidrosis.
        Cutis. 2011; 88: 43-45
        • Walling H.W.
        • Swick B.L.
        Treatment options for hyperhidrosis.
        Am J Clin Dermatol. 2011; 12: 285-295
        • Lewis D.R.
        • Irvine C.D.
        • Smith F.C.
        • et al.
        Sympathetic skin response and patient satisfaction on long-term follow-up after thoracoscopic sympathectomy for hyperhidrosis.
        Eur J Endo Vasc Surg. 1998; 15: 239-243
        • Grunfeld A.
        • Murray C.A.
        • Solish N.
        Botulinum toxin for hyperhidrosis: a review.
        Am J Clin Dermatol. 2009; 10: 87-102
        • Hamm H.
        • Naumann M.
        • Kowalski J.W.
        • et al.
        Primary focal hyperhidrosis: disease characteristics and functional impairment.
        Dermatology. 2006; 212: 343-353
        • Haider A.
        • Solish N.
        Focal hyperhidrosis: diagnosis and management.
        CMAJ. 2005; 172: 69-75
        • Kaufmann H.
        • Saadia D.
        • Polin C.
        Primary hyperhidrosis: evidence for autosomal dominant inheritance.
        Clin Auton Res. 2003; 13: 96-98
        • Solish N.
        • Benohanian A.
        • Kowalski J.W.
        • Canadian Dermatology Study Group on Health-Related Quality of Life in Primary Axillary Hyperhidrosis
        Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
        Dermatol Surg. 2005; 31: 405-413
        • Campanati A.
        • Bernardino M.L.
        • Gesuita R.
        • et al.
        Plantar focal idiopathic hyperhidrosis and botulinum toxin: a pilot study.
        Eur J Dermatol. 2007; 17: 52-54
        • Goh C.L.
        Aluminum chloride hexahydrate versus palmar hyperhidrosis. Evaporimeter assessment.
        Int J Dermatol. 1990; 29: 368-370
        • Akins D.L.
        • Meisenheimer J.L.
        • Dobson R.L.
        Efficacy of the drionic unit in the treatment of hyperhidrosis.
        J Am Acad Dermatol. 1987; 16: 828-832
        • Dolianitis C.
        • Scarff C.E.
        • Kelly J.
        • et al.
        Iontophoresis with glycopyrrolate for the treatment of palmoplantar hyperhidrosis.
        Australas J Dermatol. 2004; 45: 208-212
        • Schnider P.
        • Binder M.
        • Auff E.
        • et al.
        Double-blind trial of botulinum A toxin for the treatment of focal hyperhidrosis of the palms.
        Br J Dermatol. 1997; 136: 548-552
        • Lowe N.J.
        • Yamauchi P.S.
        • Lask G.P.
        • et al.
        Efficacy and safety of botulinum toxin type a in the treatment of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled study.
        Dermatol Surg. 2002; 28: 822-827
        • Simonetta Moreau M.
        • Cauhepe C.
        • Magues J.P.
        • et al.
        A double-blind, randomized, comparative study of dysport vs botox in primary palmar hyperhidrosis.
        Br J Dermatol. 2003; 149: 1041-1045
        • Baumann L.
        • Slezinger A.
        • Halem M.
        • et al.
        A double-blind, randomized, placebo-controlled pilot study of the safety and efficacy of myobloc (botulinum toxin type B) for the treatment of palmar hyperhidrosis.
        Dermatol Surg. 2005; 31: 263-270
        • Solish N.
        • Bertucci V.
        • Dansereau A.
        A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee.
        Dermatol Surg. 2007; 33: 908-923
        • Naumann M.
        • Dressler D.
        • Hallett M.
        • et al.
        Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders.
        Toxicon. 2013; 67: 141-152
        • Saadia D.
        • Voustianiouk A.
        • Wang A.K.
        • et al.
        Botulinum toxin type A in primary palmar hyperhidrosis: randomized, single-blind, two-dose study.
        Neurology. 2001; 57: 2095-2099
        • Campanati A.
        • Giuliodori K.
        • Martina E.
        • et al.
        Onabotulinumtoxin type A (Botox) versus incobotulinumtoxin type A (Xeomin) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial.
        J Neural Transm. 2014; 121: 21-26
        • Rystedt A.
        • Karlqvist M.
        • Bertilson M.
        • et al.
        Effect botulinum toxin concentration on reduction of sweating: a randomised, double blind study.
        Acta Derm Venereol. 2013; 93: 674-678
        • Benohanian A.
        Treatment of recalcitrant plantar hyperhidrosis with type-A botulinum toxin injections and aluminum chloride in salicylic acid gel.
        Dermatol Online J. 2008; 14: 5
        • Gregoriou S.
        • Rigopoulos D.
        • Makris M.
        • et al.
        Effects of botulinum toxin therapy for palmar hyperhidrosis in plantar sweat production.
        Dermatol Surg. 2010; 36: 496-498
        • Tracey C.
        • Vlahovic T.C.
        • Dunn S.P.
        • et al.
        Injectable botulinum toxin as a treatment for plantar hyperhidrosis. A case study.
        J Am Podiatr Med Assoc. 2008; 98: 156-159
        • Fujita M.
        • Mann T.
        • Mann O.
        • et al.
        Surgical pearl: use of nerve blocks for botulinum toxin treatment of palmar-plantar hyperhidrosis.
        J Am Acad Dermatol. 2001; 45: 587-589
        • Benohanian A.
        Needle-free anaesthesia prior to botulinum toxin type A injection treatment of palmar and plantar hyperhidrosis.
        Br J Dermatol. 2007; 156: 593-596
        • Smith K.
        Ice minimizes discomfort associated with injection of botulinum toxin type A for the treatment of palmar and plantar hyperhidrosis.
        Dermatol Surg. 2007; 33: S88-S91
        • Moraru E.
        • Auff E.
        Hyperhidrosis of the palms and soles.
        Curr Probl Dermatol. 2002; 30: 156-169
        • Torrisi B.M.
        • Zarnitsyn V.
        • Prausnitz M.R.
        • et al.
        Pocketed microneedles for rapid delivery of a liquid-state botulinum toxin A formulation into human skin.
        J Control Release. 2013; 165: 146-152
        • Solomon P.
        Modified bier block anesthetic technique is safe for office use for botulinum a toxin treatment of palmar hyperhidrosis.
        Dermatol Online J. 2007; 13: 6
        • Hayton M.J.
        • Stanley J.K.
        • Lowe N.J.
        A review of peripheral nerve blockade as local anaesthesia in the treatment of palmar hyperhidrosis.
        Br J Dermatol. 2003; 149: 447-451
        • Murray C.A.
        • Cohen J.L.
        • Solish N.
        Treatment of focal hyperhidrosis.
        J Cutan Med Surg. 2007; 11: 67-77